Evidence map›Paper›PMID 39058744›Full record

ArticlePLoS neglected tropical diseases2024

The evolutionary and molecular history of a chikungunya virus outbreak lineage.

Janina Krambrich, Filip Mihalič, Michael W Gaunt, Jon Bohlin, Jenny C Hesson, Åke Lundkvist, Xavier de Lamballerie, Cixiu Li, Weifeng Shi, John H-O Pettersson

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Genomic insights into the re-emergence of chikungunya virus on Réunion Island, France, 2024 to 2025.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  18. The Re-emergence of Chikungunya in Sri Lanka: A Genomic investigation.medRxiv : the preprint server for health sciences · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Janina KrambrichDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Filip MihaličDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Michael W GauntSolena Ag, Foster City, California, United States of America.
Jon BohlinInfectious Disease Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Jenny C HessonDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Åke LundkvistDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Xavier de LamballerieUnité des Virus Émergents (UVE), Aix-Marseille University-IRD 190-Inserm 1207, Marseille, France.
Cixiu LiKey Laboratory of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, China.
Weifeng ShiDepartment of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
John H-O PetterssonDepartment of Medical Science, Uppsala University Uppsala, Sweden.ORCID 0000-0001-6665-7492

Funding

Academic Promotion Programme of Shandong First Medical University 2019QL006European Union’s Horizon 2020 research innovation program 874735 (VEO)SciLifeLab Pandemic Preparedness LPP1-007SciLifeLab Pandemic Preparedness REPLP1:005Swedish Research Council Vetenskapsrådet 2020-02593
6 · The paper itself

Abstract

In 2018-2019, Thailand experienced a nationwide spread of chikungunya virus (CHIKV), with approximately 15,000 confirmed cases of disease reported. Here, we investigated the evolutionary and molecular history of the East/Central/South African (ECSA) genotype to determine the origins of the 2018-2019 CHIKV outbreak in Thailand. This was done using newly sequenced clinical samples from travellers returning to Sweden from Thailand in late 2018 and early 2019 and previously published genome sequences. Our phylogeographic analysis showed that before the outbreak in Thailand, the Indian Ocean lineage (IOL) found within the ESCA, had evolved and circulated in East Africa, South Asia, and Southeast Asia for about 15 years. In the first half of 2017, an introduction occurred into Thailand from another South Asian country, most likely Bangladesh, which subsequently developed into a large outbreak in Thailand with export to neighbouring countries. Based on comparative phylogenetic analyses of the complete CHIKV genome and protein modelling, we identified several mutations in the E1/E2 spike complex, such as E1 K211E and E2 V264A, which are highly relevant as they may lead to changes in vector competence, transmission efficiency and pathogenicity of the virus. A number of mutations (E2 G205S, Nsp3 D372E, Nsp2 V793A), that emerged shortly before the outbreak of the virus in Thailand in 2018 may have altered antibody binding and recognition due to their position. This study not only improves our understanding of the factors contributing to the epidemic in Southeast Asia, but also has implications for the development of effective response strategies and the potential development of new vaccines.

Indexed as

Chikungunya FeverChikungunya virusDisease OutbreaksEvolution, MolecularGenotypePhylogenyGenome, ViralHumansMutationPhylogeographySwedenThailandViral Envelope ProteinsViral Envelope Proteins

Identifiers

PMID39058744
PMCPMC11305590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.